Additionally, recent studies have identified that protein tyrosine phosphatase-1B inhibitors inhibit IL13 signal transduction, attenuating the invasive and migratory capabilities of IL13Rα2-positive GBM tumor cells, showing promising therapeutic potential in animal experiments [56]. This evidence concerns the gene PTPN1 and neoplasm.